Research focused on autism, the gut-brain axis & behavior.

It addresses an area of intense interest for ASD where therapeutic options remain limited.

The topic connects directly with Quezia’s broader interests in neuroinflammation, behavior and translational approaches.

The review found that the evidence remains limited, and larger, well-designed randomized trials are still needed to clarify effectiveness and long-term safety.

It connects experimental ASD models with cellular mechanisms that may underlie behavior and neurodevelopmental change.

The paper aligns closely with Quezia’s focus on autism, neurobiology and translational approaches.

The reviewed studies show that valproic acid can alter neural-cell development, signaling and oxidative stress, helping researchers study ASD-related mechanisms.

It highlights accessible laboratory indicators that can support the detection, severity assessment and clinical monitoring of inflammatory conditions.

The topic complements Quezia’s broader work on inflammation and translational health by connecting immune activity with measurable clinical markers.

Changes in white blood cells, platelets, C-reactive protein and related indices can provide useful clues about inflammatory activity in the body.

It addresses how antimicrobial exposure can disrupt gut ecology and immune health, with consequences that extend beyond the gastrointestinal tract.

The chapter fits Quezia’s gut-focused research trajectory by linking microbiota composition, inflammation, nutrition and therapeutic approaches.

Antibiotics can disturb beneficial gut bacteria; balanced diet, careful antibiotic use, prebiotics and probiotics are discussed as ways to support recovery.

LPS translocation links microbial imbalance with systemic inflammation and is relevant to metabolic, cardiovascular and neurodegenerative disease mechanisms.

It directly reinforces Quezia’s interests in gut inflammation and gut-brain mechanisms by focusing on how intestinal barrier disruption can influence systemic biology.

When the gut barrier is disrupted, bacterial LPS can enter circulation and promote inflammation; the chapter discusses microbiota-targeted approaches that may help restore balance.

It reflects Quezia’s work with natural products and their anti-inflammatory, antioxidant and therapeutic potential.

The work connects natural-product research with inflammation and gastrointestinal physiology, themes that are directly relevant to Quezia’s broader research trajectory.

Twelve studies were selected for the review. The literature suggests therapeutic potential, but the authors emphasize that more research is needed on clinical use, dosage and safety.

It sits directly at the intersection of autism, nutrition and the gut-brain axis, a central thread in Quezia’s work.

The study links nutritional intervention with microbiota composition, memory and autism-related behavior in an experimental model.

In this animal model, whey protein was associated with improved gut-bacteria diversity and memory outcomes, suggesting a useful path for gut-brain research.